Contrast-induced Nephropathy
57
3
6
26
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.3%
3 terminated out of 57 trials
89.7%
+3.1% vs benchmark
11%
6 trials in Phase 3/4
4%
1 of 26 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 26 completed trials
Clinical Trials (57)
Serum Electrolytes and Contrast-Induced Nephropathy in Acute Ischemic Stroke Patients Undergoing Endovascular Treatment
Acute Kidney Injury in Patients Undergoing Contrast Exposure: VQ vs. CT
Oral vs. Intravenous Hydration to Prevent Contrast-Associated Acute Kidney Injury in the ED
Clinical Validation of the RENISCHEM L-FABP POC Assay
Role of Amlodipine in Reduction of CIN
Effect of Continuing vs. Discontinuing ACE Inhibitors on Renal Function After Coronary Angiography
Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease
Trial to Assess Whether Computed Tomography Cardiac Angiography Can Improve Invasive Coronary Angiography in Bypass Surgery Patients
Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease
Early Diagnosis as Strategy in Reducing the Incidence of Contrast-induced Nephropathy
Coenzyme Q10 Role in Prevention of Contrast Induced Nephropathy in Acute Coronary Syndrome Patients.
Contrast Nephropathy Associated FFA
Risk of Acute Kidney Injury After Intravenous Contrast Computed Tomography Scans
Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 30
Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast
Time to Excretion of Contrast, a Maastricht Prospective Observational Study
Automated Prediction and Prevention of Contrast Induced Nephropathy After Cardiac Catheterization
Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography
Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury
Data on the Prevention of Complications of Prophylactic Intravenous Hydration in Patients With eGFR < 30